Zelta

some time back, i fell into a peptide rabbit hole. read everything. started experimenting. couldn't stop. then India's semaglutide patent expired in march. 25+ generics launched overnight. suddenly one of the most powerful drugs in healthcare was accessible - but nobody had built proper infrastructure around it. no GLP-1 specialists. no monitoring. no cold chain. 1 in 4 indian adults overweight or obese and the system just wasn't ready. so we built @ZeltaHealth, doctor-prescribed GLP-1s with full medical oversight, delivery, follow-ups, nutrition, blood work - the whole stack. 5,000+ registered patients later, linking up with the head of BD at Novo Nordisk - the company that pioneered GLP-1s with Ozempic and Wegovy. the peptide space in India is just getting interesting. a lot more to come.

1 in 3 Indian adults are overweight, heading to 404 million by 2030. We started Zelta to change that. Not just access to GLP-1, but real care around it. Our goal is bigger than weight loss. It's giving people their health, and their confidence, back.